Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Goralatide;seraspenide;120081-14-3;Ac-Ser-Asp-Lys-Pro;AcSDKP;Ac-SDKP;Goralatide [INN];acetyl-SDKP;Ac-Ser-Asp-Lys-Pro-OH;goralatida;acetyl-N-Ser-Asp-Lys-Pro;N-acetyl-Ser-Asp-Lys-Pro;acetyl-seryl-aspartyl-lysyl-proline;goralatidum;AcSDKP-NH2;NAcSerAspLysPro;Ac-Ser-Asp-Lys-Pro-NH2;DTXSID0057629;UNII-H041538E9P;n-acetyl-seryl-aspartyl-lysyl-proline;127103-11-1;H041538E9P;DTXCID1031418;CHEBI:191178;N-acetyl-L-Ser-L-Asp-L-Lys-L-Pro;(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carboxylic acid;(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-4-hydroxy-4-oxobutanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carboxylic acid;N-Ac-Ser-Asp-Lys-Pro;acetyl-L-seryl-L-aspartyl-L-lysyl-L-proline;L-Proline, 1-(N2-(N-(N-acetyl-L-seryl)-L-alpha-aspartyl)-L-lysyl)-;1-(N(sup 2)-(N-(N-Acetyl-L-seryl)-L-alpha-aspartyl)-L-lysyl)-L-proline;N-acetyl-L-seryl-L-alpha-aspartyl-L-lysyl-L-proline;L-PROLINE, N-ACETYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-LYSYL-;MFCD00076849;1-(N(SUP 2)-(N-(N-ACETYL-L-SERYL)-L-.ALPHA.-ASPARTYL)-L-LYSYL)-L-PROLINE;Acetyl-serinyl-aspartyl-lysinyl-proline;(2S)-1-((2S)-2-(((2S)-2-(((2S)-2-acetamido-3-hydroxypropanoyl)amino)-4-hydroxy-4-oxobutanoyl)amino)-6-aminohexanoyl)pyrrolidine-2-carboxylic acid;acetyl-seryl-aspartyl-lysyl-prolinamide;SCHEMBL669284;CHEMBL420741;N-Acetyl-Ser-Asp-Lys-Pro-OH;GTPL10060;CHEBI:168934;Tox21_113896;NCGC00261976-01;DA-53676;FA108367;DB-214753;CAS-120081-14-3;NS00121933;Q27279387;L-PROLINE, N-ACETYL-L-SERYL-L-ALPHA-ASPARTYL-L-LYSYL-;(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-Acetamido-3-hydroxypropanoyl]amino]-4-hydroxy-4-oxobutanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carboxylicacid;(S)-1-((S)-2-((S)-2-((S)-2-acetamido-3-hydroxypropanamido)-3-carboxypropanamido)-6-aminohexanoyl)pyrrolidine-2-carboxylic acid; |
M.F/Formula | C20H33N5O9 |
M.W/Mr. | 487.5 |
Sequence | One Letter Code:SDKP Three Letter Code:Ac-Ser-Asp-Lys-Pro-OH |
InChI | InChI=1S/C20H33N5O9/c1-11(27)22-14(10-26)18(31)24-13(9-16(28)29)17(30)23-12(5-2-3-7-21)19(32)25-8-4-6-15(25)20(33)34/h12-15,26H,2-10,21H2,1H3,(H,22,27)(H,23,30)(H,24,31)(H,28,29)(H,33,34)/t12-,13-,14-,15-/m0/s1 |
InChI Key | HJDRXEQUFWLOGJ-AJNGGQMLSA-N |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.